Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism?

Movement Disorders

Volumn 16, Issue 2, 2001, Pages 306-310

  Barlas, Orhan ^a   Hanaǧasi, Haşmet A ^a   Imer, Murat ^a   Şahin, Hüseyin A ^a   Sencer, Serra ^a   Emre, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hemiballism; Parkinson's disease; Subthalamic nucleus; Subthalamotomy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMIBALLISM; HUMAN; IDIOPATHIC DISEASE; INVOLUNTARY MOVEMENT; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROSURGERY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SUBTHALAMIC NUCLEUS; SURGICAL TECHNIQUE;

ADULT; AGED; DYSKINESIAS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; POSTOPERATIVE COMPLICATIONS; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS; TIME;

EID: 0035297145     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1051     Document Type: Article

References (36)

1. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339: 1105-1111.
2. Kumar R, Lozano AM, Kim YJ. Double blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855.
3. Henderson JM, Dunnett SB. Targeting the subthalamic nucleus in the treatment of Parkinson's disease. Brain Res Bull 1998;6:467-474.
4. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249:1436-38.
5. Aziz TZ, Peggs D, Sambrook MA, Crosman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4phenyl-1,2,3,6-terahydropiridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991;6:288-292.
6. Aziz TS, Peggs D, Agarwall E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposed primate. Br J Neurosurg 1992;6:575-582.
7. Guridi J, Herero M, Luquin MR, Guillen J, Obeso JA. Subthalamotomy improves MPTP-induced parkinsonism in monkeys. Stereotact Funct Neurosurg 1994;62:98-102.
8. Guridi J, Herrero MT, Luquin MR, et al. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain 1996;119:1717-1727.
9. Dierssen G, Bergmann LL, Cooper I. Hemiballism following surgery for Parkinson's disease. Arch Neurol 1961;5:63-73.
10. Brion S, Guiot G, Derome P, Comoy C. Hemiballismes postoperatoire au cours de la chirurgie stereotaxique, A propos de 12 observationsdont 2 anatomo-cliniques dans une serie de 850 interventions. Revue Neurologique 1965;112:410-443.
11. Limousin P, Pollak P, Hoffmann D, Benazzouz A, Perret JE, Benabid AL. Abnormal involuntary movements induced by subthalamic nucleus stimulation in Parkinsonian patients. Mov Disord 1996;3: 231-235.
12. Shannon KM. Hemiballismus. Clin Neuropharmacol 1990;13: 413-425.
13. Hamada I, DeLong MR. Excitotixic acid lesions of the primates subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992;68:1850-1858.
14. Crosman AR, Sambrook MA, Jackson A. Experimental hemichorea/hemiballismus in the monkey: studies on the intracerebral site of action in a drug-induced dyskinesia. Brain 1984;107:579-596.
15. Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 1993;4:421-429.
16. Guridi J, Obeso JA. The role of the subthalamic nucleus in the origin of hemiballism and Parkinsonism: new surgical perspectives. In: Obeso JA, DeLong MR, Ohye C, Marsden CD, eds. The basal ganglia and new surgical approaches for Parkinson's disease. Advances in Neurology, vol 74. Philadelphia: Lippincott-Raven;1997:235-247.
17. Inzelberg, R. Korczyn A. Persistent hemiballismus in Parkinson's disease. J. Neurol Neurosurg. Psychiatry 1994:57:1013.
18. Sellal F, Hirsch E, Lisovoski F, Metshler V, Collard M, Maresceux C. Contralateral disappearance of parkinsonian signs after subthalamic haematoma. Neurology 1992;42:255-256.
19. Vidakovic A, Dragesevic N, Kostic VS. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry 1994;57:945-949.
20. Andy OJ, Jurko MF, Sias FR. Subthalamotomy in treatment of Parkinsonian tremor. J Neurosurg 1963;20:860-870.
21. Fager CH. Evaluation of thalamic and subthalamic surgical lesions in the alleviation of Parkinson's disease. J Neurosurg 1968;28: 145-149.
22. Mundinger F. Stereotaxic intervention on the zona incerta area for treatment of extrapyramidal motor disturbances and their results. Confin Neurol 1965;26:222;230.
23. Spiegel EA, Wycis HT, Szekely EG, Adams J, Flanagan M, Baird HW. Campotomy in various extrapyramidal disorders. J Neurosurg 1963;871-884.
24. Albin R, Young AB, Penney JB. The functional anatomy of the basal ganglia disorders. Trends Neurosci 1989;12:366-375.
25. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate in MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A, eds. The basal ganglia II. New York: Plenum Press; 1987:415-427.
26. De Long MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
27. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-520.
28. Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. III. Changes in motor behaviour and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 1994;72:521-530.
29. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6,-tetrahydropiridine. Neuroscience 1989;32:213-226.
30. Mitchell IJ, Boyce S, Sambrook MA, Crossman AR. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain 1992;115:809-824.
31. Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 1993;5:382-389.
32. Obeso J, Alvarez L, Macias RJ, et al. Lesion of the subthalamic nucleus (STN) in Parkinson's disease. Neurology 1997;48(Suppl):A138.
33. Gill SS, Heywood P. Bilateral subthalamic nucleotomy can be accomplished safely. Mov Disord 1998;13(Suppl 2):P3.206.
34. Alvarez L, Marcias R, Lopez G, Maragato C, Teijero J, Torres A, Alvarez E, Pavon N, Ochoa L. Bilateral subthalamomy in Parkinson's disease. Mov Disord 1998;13(Suppl 2):P5.093.
35. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997;350:1224.
36. Starr PA, Vitek JL, DeLong M, Bakay RAE. Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery 1999;44:303-314.